Use of anti-B-cell therapy in case of antisynthetase syndrome as the severest subtype of polymyositis/dermatomyositis
Antisynthetase syndrome encompassing a symptom complex with severe interstitial lung disease is the severest subtype of polymyositis and dermatomyositis. The characteristic feature of antisynthetase syndrome is the insufficient efficiency of traditional therapy with glucocorticosteroids and cytostat...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
"Consilium Medicum" Publishing house
2014-05-01
|
| Series: | Терапевтический архив |
| Subjects: | |
| Online Access: | https://ter-arkhiv.ru/0040-3660/article/view/31534 |
| _version_ | 1828474193216274432 |
|---|---|
| author | O A Antelava A N Khelkovskaia-Sergeeva G M Tarasova N Iu Nikishina N E Lopatina S G Pal'shina T P Fedina E G Sazhina |
| author_facet | O A Antelava A N Khelkovskaia-Sergeeva G M Tarasova N Iu Nikishina N E Lopatina S G Pal'shina T P Fedina E G Sazhina |
| author_sort | O A Antelava |
| collection | DOAJ |
| description | Antisynthetase syndrome encompassing a symptom complex with severe interstitial lung disease is the severest subtype of polymyositis and dermatomyositis. The characteristic feature of antisynthetase syndrome is the insufficient efficiency of traditional therapy with glucocorticosteroids and cytostatics, which determines the prognosis of the disease and the need for new therapeutic approaches to treating these patients. |
| first_indexed | 2024-12-11T05:55:55Z |
| format | Article |
| id | doaj.art-fdd298322f1340a58456b5e76f6a73a6 |
| institution | Directory Open Access Journal |
| issn | 0040-3660 2309-5342 |
| language | Russian |
| last_indexed | 2024-12-11T05:55:55Z |
| publishDate | 2014-05-01 |
| publisher | "Consilium Medicum" Publishing house |
| record_format | Article |
| series | Терапевтический архив |
| spelling | doaj.art-fdd298322f1340a58456b5e76f6a73a62022-12-22T01:18:40Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422014-05-0186510911528550Use of anti-B-cell therapy in case of antisynthetase syndrome as the severest subtype of polymyositis/dermatomyositisO A AntelavaA N Khelkovskaia-SergeevaG M TarasovaN Iu NikishinaN E LopatinaS G Pal'shinaT P FedinaE G SazhinaAntisynthetase syndrome encompassing a symptom complex with severe interstitial lung disease is the severest subtype of polymyositis and dermatomyositis. The characteristic feature of antisynthetase syndrome is the insufficient efficiency of traditional therapy with glucocorticosteroids and cytostatics, which determines the prognosis of the disease and the need for new therapeutic approaches to treating these patients.https://ter-arkhiv.ru/0040-3660/article/view/31534polymyositisdermatomyositisantisynthetase syndromerituximabinterstitial lung disease |
| spellingShingle | O A Antelava A N Khelkovskaia-Sergeeva G M Tarasova N Iu Nikishina N E Lopatina S G Pal'shina T P Fedina E G Sazhina Use of anti-B-cell therapy in case of antisynthetase syndrome as the severest subtype of polymyositis/dermatomyositis Терапевтический архив polymyositis dermatomyositis antisynthetase syndrome rituximab interstitial lung disease |
| title | Use of anti-B-cell therapy in case of antisynthetase syndrome as the severest subtype of polymyositis/dermatomyositis |
| title_full | Use of anti-B-cell therapy in case of antisynthetase syndrome as the severest subtype of polymyositis/dermatomyositis |
| title_fullStr | Use of anti-B-cell therapy in case of antisynthetase syndrome as the severest subtype of polymyositis/dermatomyositis |
| title_full_unstemmed | Use of anti-B-cell therapy in case of antisynthetase syndrome as the severest subtype of polymyositis/dermatomyositis |
| title_short | Use of anti-B-cell therapy in case of antisynthetase syndrome as the severest subtype of polymyositis/dermatomyositis |
| title_sort | use of anti b cell therapy in case of antisynthetase syndrome as the severest subtype of polymyositis dermatomyositis |
| topic | polymyositis dermatomyositis antisynthetase syndrome rituximab interstitial lung disease |
| url | https://ter-arkhiv.ru/0040-3660/article/view/31534 |
| work_keys_str_mv | AT oaantelava useofantibcelltherapyincaseofantisynthetasesyndromeastheseverestsubtypeofpolymyositisdermatomyositis AT ankhelkovskaiasergeeva useofantibcelltherapyincaseofantisynthetasesyndromeastheseverestsubtypeofpolymyositisdermatomyositis AT gmtarasova useofantibcelltherapyincaseofantisynthetasesyndromeastheseverestsubtypeofpolymyositisdermatomyositis AT niunikishina useofantibcelltherapyincaseofantisynthetasesyndromeastheseverestsubtypeofpolymyositisdermatomyositis AT nelopatina useofantibcelltherapyincaseofantisynthetasesyndromeastheseverestsubtypeofpolymyositisdermatomyositis AT sgpalshina useofantibcelltherapyincaseofantisynthetasesyndromeastheseverestsubtypeofpolymyositisdermatomyositis AT tpfedina useofantibcelltherapyincaseofantisynthetasesyndromeastheseverestsubtypeofpolymyositisdermatomyositis AT egsazhina useofantibcelltherapyincaseofantisynthetasesyndromeastheseverestsubtypeofpolymyositisdermatomyositis |